Skip to main content

Table 1 Characteristics of the patients completing the study

From: A real – life observational pilot study to evaluate the effects of two-week treatment with montelukast in patients with chronic cough

Characteristics of patients (n = 14) Variables format and values
Age [years] Mean = 43, Standard deviation = 17
Gender [number (%)] Females = 9 (64), Males = 5 (36)
Atopy [number (%)] 3 (14)
Total IgE [IU/mL] Median = 69.9, Range = 28.2 ÷ 96.6
Rhinitis symptoms [number (%)] 12 (86)
GER [number (%)] 5 (36)
Duration of cough (weeks) Mean = 27, Range = 8 ÷ 72
LCQ score before treatment Mean = 12.4, Standard deviation = 3.36
FSSG score Mean = 9.9, Standard deviation = 7.8
FVC% predicted before treatment Mean = 110.6, Standard deviation = 19.9
FEV1% predicted before treatment Mean = 111.2, Standard deviation = 19.2
EBT before treatment Mean = 34.46, Standard deviation = 0.54